Skip to main content
AAO-HNSF 2023 Annual Meeting & OTO Experience Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Sleep Medicine

Updates From the International Consensus Statement on Obstructive Sleep Apnea

Monday, October 2, 2023
8:45 AM - 9:35 AM East Coast USA Time
Location: Ballroom A1

    Moderator(s)

  • Jolie L. Chang, MD

    Associate Professor, Otolaryngology HNS
    University of California San Francisco
    San Francisco, CA, United States

    • Panelist(s)

  • Megan L. Durr, MD, FACS

    Associate Professor
    University of California, San Francisco
    San Francisco, CA, United States

  • AG

    Andrew N. Goldberg, MD, MSCE

    Professor
    University of California San Francisco
    San Francisco, CA, United States

  • Ilene M. Rosen, MD, MSCE

    Associate Professor of Medicine
    Hospital of the University of Pennsylvania
    Philadelphia, PA, United States

Disclosure(s):
Jolie L. Chang, MD: No relevant relationships to disclose.
Megan L. Durr, MD, FACS: No relevant relationships to disclose.
PROGRAM DESCRIPTION: There is growing interest and need for the evaluation of obstructive sleep apnea (OSA) in an era where multiple medical and surgical therapies are available. Otolaryngology providers play key roles in counseling and helping patients navigate the best course of action for managing OSA and associated symptoms. Multidisciplinary approaches are essential to optimizing patient outcomes.

The International Consensus Statement on OSA (ICS-OSA), published in 2022, was developed by a group of 140 international experts in sleep medicine, otolaryngology, sleep surgery, oral surgery, neurology, psychiatry, and dentistry. The statement summarizes the latest scientific evidence on OSA. It is intended to provide an up-to-date resource to help healthcare professionals make informed decisions about the diagnosis and treatment of OSA with medical and surgical therapies.

This panel includes the co-editors of the ICS who will present updates on key topics addressed in the ICS including contemporary surgeries for OSA and comparisons of outcomes with medical and surgical therapies. The panelists will also present factors that contribute to patient selection for surgical candidacy and discuss how to best counsel patients using the most current evidence.

OUTCOME OBJECTIVE 1: Evaluate the evidence for medical and surgical treatments and efficacy for OSA.

OUTCOME OBJECTIVE 2: Understand the varied definitions of success in OSA evaluation and treatment discussions.

OUTCOME OBJECTIVE 3: Review factors for determining surgical candidacy and understand the impact on surgical outcomes.

BACKGROUND STATEMENT: The ICS-OSA 2022 is a rich resource that lays out both medical and surgical perspectives on OSA care. Implementing the information into practice is a need for most otolaryngologists who counsel OSA patients on care.